OVS (OVS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
16 Dec, 2025Executive summary
Achieved record first-half results with net sales of €792.9 million, up 4.1% year-over-year, driven by strong performance in women's apparel, beauty, and the first-time consolidation of Goldenpoint.
Net income rose 31.7% to €45.6 million, supported by EBITDA growth and margin expansion.
Women's segment, led by Les Copains and Piombo, and the beauty category delivered strong double-digit growth and higher margins.
Goldenpoint contributed €15 million in sales in July and boosted overall results since consolidation.
Like-for-like August sales showed double-digit growth, with September also performing well.
Financial highlights
Net sales reached €792.9 million (+4.1%); gross margin improved to 60.7%; adjusted EBITDA increased to €101.7 million (+14.3%), with margin at 12.8%.
Net income at €45.6 million, up 31.7% year-over-year; EBIT at €69.2 million (+20.8%).
Net financial debt as of July 31, 2025, was €293.6 million, reflecting Goldenpoint consolidation and seasonality.
Working capital remained stable; inventory elevated due to Suez Canal disruption and anticipated purchases.
Treasury shares in portfolio represent 4.297% of share capital as of September 16, 2025.
Outlook and guidance
Full-year growth expectations confirmed, with strong sales momentum continuing into the second half and double-digit like-for-like August sales.
Expect mid-single-digit revenue growth for the year, with Goldenpoint contributing €60 million in H2 sales.
Free cash flow forecasted at €70 million for the year, with Goldenpoint's contribution expected to be neutral.
CapEx guidance for the year is €70–75 million, with a sharper drop expected from 2026.
Gross margin for the full year expected to remain above last year, with some benefit from favorable FX hedging in 2026.
Latest events from OVS
- Q1 sales and margins rose, with strong brand momentum and a positive outlook for 2024.OVS
Q1 20253 Feb 2026 - Sales and margins rose in H1 2024, with strong September momentum and positive outlook.OVS
Q2 202520 Jan 2026 - Q3 2024 delivered double-digit sales and EBITDA growth, with robust outlook and share buybacks.OVS
Q3 202511 Jan 2026 - Sales up 6.2%, margins and cash flow improved, with higher dividend and buyback ahead.OVS
Q4 202523 Dec 2025 - Sales and EBITDA up, leverage improved, and outlook remains positive for year-end.OVS
Q3 202618 Dec 2025 - Q1 sales grew 0.6% to €354.4m; Goldenpoint synergies and Q2 momentum support a positive outlook.OVS
Q1 202614 Nov 2025